CCL2 and neoplasm: Conversely, cMSCs promoted tumor cell growth (including breast cancer, hepatocellular carcinoma and glioblastoma) through NO-mediated immunosuppression and MCP-1- and IL-6 -mediated macrophage trafficking and polarization towards an M2-like phenotype.